Articles
Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes
Previous cohort studies have focused mainly on statin foetal outcomes, with limited evidence about maternal cardiovascular health, particularly in high-risk women.
Discontinuing statin therapy before pregnancy remains challenging, especially in high-risk women. We evaluated the risks of maternal cardiovascular, gestational, and foetal outcomes associated with continuing versus discontinuing statin therapy before the last menstrual period (LMP).
Click here to access the article.